Select Conferences | Advances in Antibody and Peptide Therapeutics 2010

Welcome to the inaugural Advances in Antibody and Peptide Therapeutics conference and exhibition which was held in the exciting city of Berlin.

The conference was co-located with the Cancer Proteomics meeting. Registered delegates had access to both meetings ensuring a very cost-effective trip.

Plenary Speaker

Mehdi Mesri
Program Manager
Office of Clinical Cancer Proteomics Research
National Institute of Health

Keynote Speakers

Renata Pasqualini
Professor
MD Anderson Cancer Center

Peter Senter
Department Head
Seattle Genetics

Sponsorship and Exhibition Opportunities
Aaron Woodley, Exhibition Manager
a.woodley@selectbiosciences.com
+44 (0)1787 315129

Big savings on group bookings!
Click here for more information.

Distinguished Speakers:
Deborah O'Neil CSO/CEO, NovaBiotics
Marie Paule LeFranc Professor, University of Montpellier
Markus Gruetter Professor, Biochemisches Institut, Switzerland
Tobias Raum Micromet-Inc
Roland Kontermann Professor, University of Heidelberg
Stefan Dubel Professor, Institute of Biochemistry and Biotechnology Spielmannstr
Vincent De Groot CEO, Syntarga
Christian Heinis Professor, EPFL
Chris Ullman CEO, Isogenica
Johannes Winkler Assistant Professor, University of Vienna
Alessandro Pocai Senior Research Fellow, Merck & Co.
Jenny Wu CEO, Acaduceus Pharmaceutics
Keith Foster Head of Technology Department, Syntaxin
Hans Baumeister Head of Services, Glaycotope
Kristian Jensen Chief Operating Officer, Pieris